Moore Capital Management’s BioVie BIVI Stock Holding History

Moore Capital Management’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-927	Closed	-$316K	–	454
2023 Q3	$316K	Buy	+927	New	+$362K	0.01%	355

Other funds holding BIVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moore Capital Management's BIVI Position: Q4 2023 in Review

Moore Capital Management sold out of BioVie (BIVI) in Q4 2023, closing a stake of 927 shares — an estimated $316K sold.

Moore Capital Management first reported a position in BIVI in Q3 2023 and held it in 1 quarter. The position peaked at $316K in Q3 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q4 2023.

Moore Capital Management reported no remaining BioVie position as of Q4 2023 after selling out during the quarter.
Moore Capital Management sold 927 BioVie shares in Q4 2023, an estimated $316K.
Moore Capital Management first reported a position in BioVie in Q3 2023 and held it in 1 quarter.
Moore Capital Management's BioVie position peaked at $316K in Q3 2023.
53 funds tracked by Wall St. Rank held BioVie as of Q4 2023.

Based on Moore Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.